Medicaid
Urge Congress to Protect Cancer Patients on Medicaid
Urge Congress to Protect Cancer Patients on Medicaid
Charles Gaulin, MBBS, of Dartmouth Geisel School of Medicine, discussed the safety and efficacy of CD19 CAR-T cell therapy for patients with transformed indolent lymphoma.
The agent produced favorable safety results, had no dose-limiting toxicities, and did not interfere with CAR T-cell therapy.
Nurses: Nominate your oncology nursing peers and colleagues who demonstrate resilience, role modeling, and high-level patient care for the inagural CNT CARE Award.
The American Lung Association is “turning the nation turquoise” for Lung Cancer Action Week and the LUNG FORCE Turquoise Takeover by lighting up monuments.
JACC: Advances is calling for papers for a special focus issue on
Examining a large national cancer registry, we observed a higher incidence of PR in patients with UTUC receiving NAC, validating findings of prior studies. Our…
Offering the most up-to-date, comprehensive lens on the global burden of cardiovascular diseases (CVDs) and risk factors, JACC, the Institute for Health Metrics and Evaluation,…
AbstractBackgroundArrhythmogenic cardiomyopathy (ACM) patients in China exhibit unique genetic and clinical characteristics. There is a lack of prognostic models specific to Chinese ACM patients.Ob…
Examining a large national cancer registry, we observed a higher incidence of PR in patients with UTUC receiving NAC, validating findings of prior studies. Our…